Biotech Week articles from May 2003

Biotech Week archives from May 2003

Study offers new insights into angiogenesis inhibitors.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- In working to halt the overgrowth of blood vessels that feed cancerous tumors, the antiangiogenic molecules endostatin and tumstatin take two distinct and very different tactics, according to a new...

Dangerous interaction between cholesterol-lowering drug and antidiabetic drug.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Researchers from the University of Helsinki, Finland, have found that the cholesterol-lowering agent gemfibrozil (marketed as Lopid and generics) greatly increases the concentrations of repaglinide...

Fibrin-based biomaterials can deliver human growth factors to healing wounds.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Fibrin-based biomaterials can deliver human growth factors to healing wounds. According to published research from the United States, "fibrin-based biomaterial preparations can be used as...

HIV vaccine candidate taken by into phase I trial in U.S., Africa.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that the National Institute of Allergy and Infectious Diseases, a component of the U.S. National Institutes of Health (NIH), holds an active Investigational New Drug...

ICA-17043 prevents erythrocyte dehydration in mice.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- A novel Gardos channel inhibitor prevents erythrocyte dehydration in mice with sickle cell anemia. According to recent research from the United States, "a prominent feature of sickle cell anemia is...

Tumor cells in blood may indicate more aggressive cancer.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- If patients with breast cancer have tumor cells circulating in the blood, they may have a more dangerous form of the disease, according to a study by researchers at the University of Texas M.D. Anderson...

New advisory board members named to Canadian biotech company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Gilles Gagnon, president and CEO at AEterna Laboratories, Inc., (AEL; AELA) announced several appointments to its Scientific Advisory Board. Fernand Labrie, director of research at the CHUL Research...

Automated hemozoin blood test effective.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- An automated hemozoin screen enabled routine testing of blood samples for malaria. "Laboratory tests for malaria are only performed if there is clinical suspicion of the disease, and a missed...

Drug maker reports 9.3%s sales increase.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories reported an increase in sales for the first quarter ended March 31, 2003. Worldwide sales for the quarter were $4.580 billion, up 9.3% from $4.189 billion in the first quarter...

Patient factors, site of care influence antibiotic prescription.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Patient characteristics and the location of care were both factors that influenced the choice of antibiotic prescribed for patients with community-acquired pneumonia (CAP), according to a new study. ...

Antiviral drug discovery alliance signed.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals, Inc., and Entomed SA, have entered into a collaboration to jointly discover and develop novel antiviral drugs. The partnership will focus on the discovery of new lead...

Key patents issued for antibiotics, antivirals.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corporation announced the issuance of U.S. Patent No. 6,544,555, entitled "Antibiotic Product, Use and Formulation Thereof" and U.S. Patent No. 6,541,014, entitled "Antiviral...

Study: Prelief may improve quality of life.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- According to a study conducted by Michael J. Kennelly, MD, of Carolinas Medical Center in North Carolina, the dietary supplement Prelief is effective in significantly improving quality of life for...

Organon, Ligand confirm full, on-schedule start of Avinza copromotion.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Organon, a business unit of Akzo Nobel (AKZOY), and Ligand (LGND) have begun full copromotion of Ligand's Avinza (morphine sulfate extended-release capsules), the first true once-daily opioid for...

Human adherent monocytes/macrophages can now be isolated and cryopreserved.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Human adherent monocytes/macrophages from mononuclear cell apheresis preparations can be isolated and cryopreserved. "There is evidence from animal and human study that suggests clinical use of...

Farr promoted to senior VP, chief scientific officer of drug delivery company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM), a leader in pulmonary drug delivery, announced the promotion of Stephen Farr to Senior VP and chief scientific officer. Farr joined Aradigm in 1995 as director,...

De Souza named president, CEO.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Archemix Corp., the biopharmaceutical company developing aptamer therapeutics, announced the appointment of Errol De Souza as president and CEO. De Souza, most recently president and CEO of Synaptic...

Endometriosis doesn't appear premalignancy-based when tested for clonality.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Endometriotic foci do not appear to be premalignant when tested for clonality. According to recent research published in the FASEB Journal, "Since 1925, epidemiological and histological evidence for...

Statement released on reported ANDA filing for a generic Enoxaparin.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Aventis learned that an Abbreviated New Drug Application (ANDA) for a generic version of Clexane /Lovenox (enoxaparin sodium injection) has been received by the Office of Generic Drugs. However,...

New president, CEO named at biopharmaceutical company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- AviGenics, Inc., announced that Yashwant Deo has been named the company's president and CEO. He has also been elected a member of the board of directors. Deo succeeds Carl Marhaver, who has been named...

New technology neutralizes viruses, bacteria, spores.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Bio-Defense Research Group, Inc., (BDRGI) a biotechnology firm based in Maryland, announced the availability of Path-Away, a technology that neutralizes deadly airborne bioterror agents such as anthrax...

New set of tools helps pharmaceutical companies improve efficiency.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- BioInnovators, Inc., in conjunction with JRS Pharma LP (formerly the excipient business of Penwest) - have developed the concept of Excipio Economics. This new set of tools is designed to help...

Sucanon regulatory response announced for insulin sensitizer.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIOHF.OB: OB; BIO.V), stated the company has provided regulatory authorities in Mexico with a further statistical analysis of clinical tests of Sucanon,...

Rautsola named as CEO at Danish biotech company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Borean Pharma A/S has appointed Riku Rautsola, 49, as president and CEO. Rautsola will succeed cofounder Hans Christian Thoegersen, who will now focus on the further development of the company's...

Murine monoclonal antibody activates platelets.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Bristol Myers Squibb Co. scientists have followed up earlier research on the etiology of thrombocytopenia with work showing "that a murine monoclonal antibody binds to glycoprotein IIb/IIIa in an...

Stress test with Cardiolite is effective in predicting cardiac events.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- The results of a new study demonstrate that regardless of race, patients with a normal stress test with Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) have an excellent...

The UMD-p53 database is useful for research on p53 related mutations.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- The UMD-p53 database has a new series of modules and data useful for research on p53 related mutations. According to recent research published in the journal Human Mutation, "The tumor suppressor...

NEOUCOM shares $1.1 million U.S. grant for development of CEL-1000.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Northeastern Ohio Universities College Of Medicine (NEOUCOM) has been awarded a $1.1 million grant for collaborative studies with Cel-Sci Corp. (CVM) to support the research of Ken S. Rosenthal, PhD,...

Inhibitors of novel cancer target attack tumor on two fronts.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI) has presented data on a novel cancer target, LPAAT-beta. The data suggest that the inhibition of LPAAT-beta may impede the growth of tumors on two fronts, by...

Update provided on Pfizer collaboration.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- ChondroGene Limited (YDG) reported that it has received a CDN$1.58 million payment from Pfizer Inc (PFE) in conjunction with achieving the first research milestone in the joint Pfizer/ChondroGene target...

NaPro announces sale of technical and analytical services group.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- NaPro BioTherapeutics, Inc., (NPRO) has sold its technical and analytical services group to privately-held ChromaDex, Inc., a leading supplier of phytochemical reference standards for the nutraceutical,...

New CEO named at pharmaceutical company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Chugai Pharma USA, LLC (CPUSA), a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd., announced the appointment of David J. Mazzo, a veteran executive with more than 20 years of international...

Clinical diagnostics executive added to board of biotech company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Ciphergen Biosystems, Inc., (CIPH) announced that Rajen Dalal, president and CEO of Guava Technologies, Inc., has joined Ciphergen's board of directors. Rajen joined Guava, a biotechnology company...

Lung cancer study combines gene expression and protein expression.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Ciphergen Biosystems, Inc., (CIPH) announced that Dr. Lin Ji from the University of Texas M. D. Anderson Cancer Center published work in the Proceedings of the American Association for Cancer Research's...

Drug discovery agreement involves supply of assay system.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- CompleGen, a genetics-based drug discovery company, and Berlex Biosciences, a U.S. affiliate of Schering, A.G., Germany, have entered into an agreement whereby CompleGen is supplying Berlex with a high...

50 representatives added to orthopedic sales force.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Conmed Corporation (CNMD) announced that it will increase the size of its orthopedic sales force in the United States by approximately 25%. The U.S. orthopedic sales force will grow from 180 to 230...

Gilbert nominated to dermatology company's board of directors.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Connetics Corporation (CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, announced that Denise M. Gilbert, PhD, has been nominated to stand for election to...

Virucort may slow development of HIV.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Cortisol Medical Research has announced a new drug that may slow the development of HIV. Virucort is a drug developed by Dr. Alfred T. Sapse that has the potential of slowing down or even preventing...

Company is prepared for new EMEA electronic reporting regulations.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Covance, Inc., (CVD) has successfully completed the first test of delivering safety adverse event (SAE) reports electronically to the European Agency for Evaluation of Medicinal Products (EMEA). ...

A computerized medical needle drive can mimic a clinical practitioner.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- A computerized medical needle drive can mimic a clinical practitioner. According to recent research from Canada, "We describe the construction and test performance of a computer-controlled medical...

Stem cell company earns accreditation by blood banks association.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Cryo-Cell International, Inc., (CCEL) has been granted accreditation by the American Association of Blood Banks (AABB). "The American Association of Blood Banks is a leader in the development of...

Gabriel named president, CEO at genomics company.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- DNAPrint genomics, Inc., (DNAP) announced the board of directors appointed Richard Gabriel as president and CEO. DNAPrint's founder, chief scientific officer, and board member, Tony Frudakis, PhD,...

A cell-free, direct protein synthesis method from DNA has been developed.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Protein arrays can be created in vitro through direct synthesis from PCR DNA, with a tag to fix it to the surface. According to recent research published in the Journal of Immunological Methods,...

Humanized lung surfactant exhibits anti-inflammatory properties.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Discovery Laboratories, Inc., (DSCO) announced that research at the University of Pennsylvania Department of Medicine, Pulmonary, Allergy and Critical Care Division has shown that Discovery's humanized...

Israeli company to use software to expedite clinical trial.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Document Solutions Group, Inc., (DSG), a provider of clinical trial data collection software and services, announced that Teva Neuroscience, a subsidiary of Teva Pharmaceuticals, has selected its...

Lankau named president, chief operating officer.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Endo Pharmaceuticals, Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings, Inc., (ENDP), announced that Peter A. Lankau, senior VP, U.S. Business, has been named president and chief...

Standstill period ended; alliance moves forward.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD) announced that the standstill period pursuant to the Celgene agreement has ended effective Midnight, March 31, 2003. In addition, the company is moving towards expanding its...

Patent issued for compounds defining new platform technology.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Entropin, Inc., (ETOP) announced that it's patent, U.S. 6,482,831, entitled, "Covalently Coupled Benzoylecgonine, Ecgonine and Ecgonidine Derivatives," has been allowed by the U.S. Patent and Trademark...

Protein Design Labs completes acquisition.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Protein Design Labs (PDL), Inc., (PDLI) has completed its acquisition of privately held Eos Biotechnology, Inc., a pioneer in the discovery of therapeutic antibodies based on information from the human...

Common stock delisted from NASDAQ.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Essential Therapeutics, Inc., (ETRX) announced that it received notice from The NASDAQ Market, Inc., that the company's common stock will be delisted from trading on The NASDAQ National Market effective...

France's commitment to vaccines will help to save children from health risks.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- At the European Society for Paediatric Infectious Diseases, Jimmy Voisine, president of the Audrey Association, announced his support for the recent French decision to reimburse the vaccine which helps...

Lead discovery alliance focused on assay development.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Evotec OAI (EVT), a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, announced that it has signed an assay development and screening...

Study offers potential explanation of complications from birth control pills.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- When women think about birth control, estrogen, and cardiovascular risk, they often assume that there are no answers. They would appear to be correct. On the one hand, new pharmacological...

Adenovirus vector shows promise.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel vector shows promise for use in HIV and other vaccines, researchers in Maryland say. "A strategy to circumvent immune responses to adenovirus (Ad)...

FDA approves Factive for treatment of respiratory tract infections.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- GeneSoft Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Factive (gemifloxacin) for the treatment of mild-to-moderate community-acquired pneumonia (CAP)...

NASDAQ delisting notification to be appealed.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (GNBT) announced that the NASDAQ Listing Qualifications Department ("the Staff") has notified the company that it is not in compliance with the requirements of NASD...

The wine derivative resveratrol alters genetic expression in cancer cells.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- The wine derivative resveratrol alters genetic expression in cancer cells. "Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural compound found in large quantities, most notably in grapes and...

Study: Biomarkers may determine responsiveness to Ganite.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Genta, Inc., (GNTA) announced presentation of laboratory data suggesting that it may be possible to determine patterns of response and resistance to Genta's newest anticancer drug, Ganite (gallium...

Drug discovery, development research grant program announced.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) will award $500,000 in grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic. ...

New data suggest rosiglitazone may also lower cardiovascular disease risk.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- New data presented at the 52nd Annual Scientific Session of the American College of Cardiology showed that the type 2 diabetes treatment rosiglitazone increased "good" cholesterol levels and improved...

Enrollment closes for Hemolink trial.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Hemosol, Inc., (HMSL) announced that to perform a full safety and efficacy analysis of its cardiac trial (HLK 213/304) for its lead product Hemolink (hemoglobin raffimer), it will close enrollment at...

French prostheses company purchased.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Heritage Worldwide, Inc., entered into an acquisition agreement dated February 28, 2003, with Milo Finance, S.A., a Luxembourg limited liability entity. Milo was the principal shareholder of Poly...

FDA issues an approvable letter for Vitrase.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced that the company has received an approvable letter from the U.S. Food & Drug Administration (FDA) with respect to ISTA's New Drug Application (NDA) for...

Positive hepatitis C, hepatitis B treatment results released.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Idenix Pharmaceuticals, Inc., presented positive preclinical results of NM283, its hepatitis C virus (HCV) clinical drug candidate, at the 11th International Symposium on Viral Hepatitis & Liver Disease...

Efficacy results of DB289 in pneumonia trial released.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMMT) announced the completion of a pilot phase IIa human clinical trial of its oral drug DB289 to treat AIDS patients with Pneumocystis carinii pneumonia (PCP), a form of...

Reimbursement coverage expanded for the Lap-Band system.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Inamed Corp. (IMDC) has announced that Humana, Inc. has expanded its coverage guidelines to include the Lap-Band System as a covered benefit for the treatment of morbid obesity. Headquartered in...

Phase II results evaluating Actimmune to be released.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) announced that results of a randomized, double-blind, placebo-controlled phase II clinical trial evaluating Actimmune's (interferon gamma-1b) influence on several underlying...

Stockholder approval of proposed financing recommended.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- IntraBiotics Pharmaceuticals, Inc., (IBPI) announced that it will file a supplemental proxy statement and recommends that stockholders approve the proposed financing transaction described in the...

Finger lancet blood sample can be used in rapid test for apolipoproteins.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- A finger lancet blood sample can be used in a rapid spectrometric immunoassay test for apolipoproteins. According to published research from the United States, "Novel mass spectrometric...

Increased responsibilities announced for key senior management.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Inveresk Research Group, Inc., (IRGI) announced increased responsibilities for two group executive VPs, with immediate effect. Alastair S. McEwan, president of Inveresk's clinical operations in the...

Additional phase II trial of Alicaforsen planned.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced it has initiated a phase II clinical trial of alicaforsen (ISIS 2302), an antisense inhibitor of intercellular adhesion molecule-1 (ICAM-1), in people with...

Jarvik 2000 device can be implanted without cardiopulmonary bypass.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Jarvik 2000 device can be implanted without cardiopulmonary bypass. According to published research from the United States, "In this report, we describe successful implantation of a Jarvik 2000 left...

New products to address SARS.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- JohnsonDiversey, Inc., has announced a package of products recognized by the U.S. Environmental Protection Agency (EPA) to kill viruses with similar properties as the SARS virus. While no specific...

Summers named director at CRO.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Kendle International, Inc., (KNDL) announced that Malcolm Summers, PhD, has joined them as director, European Regulatory Consulting and Submissions. Working closely with Kendle's AAC Consulting...

Open-label safety study of Riquent closed.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Company (LJPC) announced that it is in the process of closing its open-label follow-on safety study of Riquent to conserve resources in order to continue the development of...

Neptune Technologies & Bioressources products now available in Quebec.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Neptune Technologies & Bioressources, Inc., (NTB) is partnering with Laboratoire LALCO of Quebec, Canada. On March 24, 2003, Neptune Technologies & Bioressources, Inc., signed a distribution...

Canada issues patent to protect invention of antisense antimicrobial drugs.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., announced that the Canadian Patent Office has allowed a patent to protect a new component of the company's antisense drug development program that shows promising antimicrobial...

Northeastern University enters genomics discovery agreement.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Lynx Therapeutics, Inc., (LYNX) announced that it has entered into a service agreement with Northeastern University to study the regulation of gene expression in Antarctic icefish using Lynx's Massively...

Trials for drug-absorption enhancer, SEPA, now cleared to resume.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- MacroChem Corp. (MCHM) announced that the U.S. Food & Drug Administration (FDA) has lifted its October 2002 clinical hold on human trials of topical drugs utilizing the company's patented...

NovaDel Pharma enters license and development agreement.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- NovaDel Pharma, Inc., (NVDL) and Manhattan Pharmaceuticals, Inc., (MHTP) announced they have entered into a license and development agreement for the worldwide, exclusive rights to NovaDel's proprietary...

Phase II trial approved for oral phenoxodiol at Royal North Shore Hospital.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Pharmaceutical company, Novogen, Ltd., (NVGN) through its associated company Marshall Edwards, Inc., has commissioned a phase II clinical study of its novel anticancer drug, phenoxodiol, on skin...

Amino acid residues confer temperature sensitivity to influenza virus strains.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Multiple amino acid residues conferred temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. "FluMist influenza A vaccine strains...

Rapid HIV test earns regulatory approval for China.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- MedMira, Inc., (MIR) announced that it has received approval from the State Drug Administration (SDA) of the People's Republic of China for its MiraWell Rapid HIV Test. According to Stephen Sham,...

Percutaneous CT stabilization relieves pain from sacroiliac metastases.
May 7, 2003... 2003 MAY 7 - (NewsRx.com & NewsRx.net) -- Percutaneous CT stabilization relieves pain from sacroiliac metastases. According to recent research from the United States, "Metastases to the sacroiliac joint region can be a source of...